Awardee OrganizationUNIVERSITY OF PITTSBURGH AT PITTSBURGH
Description
Abstract Text
PROJECT SUMMARY
The ongoing theme of this program is to study the virus-cell interactions that affect HSV gene
expression, with the primary focus on the mechanisms that regulate viral and cellular transcription during the
course of infection. Progress during the last funding period has provided new insights into how the genes of
HSV are transcribed in a regulated cascade during the course of viral infection. The studies also showed how
viral processes and molecules can interact with and possibly regulate cellular transcription. We propose to
extend on these studies and investigate new virus-cell interactions that affect virus and cell transcription.
Ultimately, knowledge of how HSV genes are transcribed, and the virus-cell interactions that contribute to their
regulated expression, may allow for strategies to block activated transcription and hence virus multiplication.
The HSV genome during productive infection is a much more dynamic structure than classic cellular
chromatin. The viral nucleoprotein allows for the rapid progression through the infectious cycle so that by 3hpi,
all the events that must occur on the viral genome to produce new virus can be observed. This includes events
that contribute to the shutoff of host cell transcription. This renewal focuses on virus-cell interactions occurring
on the cellular (aim 1) and viral (aim 2) genomes, as well as the utilization of a cellular complex by the virus
that is crucial for all pol II transcription, the mediator (aim 3). We have shown that the major viral regulatory
protein, ICP4, binds to promoter/start-site regions of specific cellular genes early in infection as a function of
the epigenetic state of the cell. The first aim will investigate the mechanism of interaction between ICP4 and
the cellular genome, determine how ICP4 affects its expression, and explore the possibility that it functions
differently in different cell types. The second will focus on the structure of the viral genome, and how viral
proteins, including ICP4, affect the accessibility of the genome, and hence viral transcription. During the last
funding period we showed that ICP4 interacts with and recruits a specific form of the mediator to the viral
genome. In the third aim we will further explore the ICP4-mediator interaction, and test a model for the
recruitment of mediator by ICP4 and its utilization for the activated and regulated transcription of viral genes.
To undertake these studies, we have developed and refined a set of proteomics and genomics tools to
specifically probe the dynamic state of viral genomes, and the viral and cellular proteins that associate with
them. These tools combined with virus genetics allows us to elucidate the mechanistic underpinnings of
processes occurring on the viral genome, including transcription.
Public Health Relevance Statement
PROJECT NARRATIVE
The ongoing theme of this program is to study the virus-cell interactions that affect HSV gene expression.
Detailed knowledge of how HSV genes are transcribed, and the virus-cell interactions that contribute to their
regulated expression, may allow for strategies to block activated transcription and hence virus multiplication.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
004514360
UEI
MKAGLD59JRL1
Project Start Date
01-March-1992
Project End Date
31-October-2026
Budget Start Date
01-November-2023
Budget End Date
31-October-2024
Project Funding Information for 2024
Total Funding
$560,188
Direct Costs
$358,216
Indirect Costs
$201,972
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Allergy and Infectious Diseases
$560,188
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI030612-28
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI030612-28
Patents
No Patents information available for 5R01AI030612-28
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI030612-28
Clinical Studies
No Clinical Studies information available for 5R01AI030612-28
News and More
Related News Releases
No news release information available for 5R01AI030612-28
History
No Historical information available for 5R01AI030612-28
Similar Projects
No Similar Projects information available for 5R01AI030612-28